Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neural Prolotherapy vs Corticosteroid for Anserine Bursitis
NCT04509440Completed
- Sponsor
- Alexandria University
- Start
- May 2018
- Primary completion
- Oct 2019
- Countries
- 1
01
Overview
Randomised trial of dextrose in Pes anserine bursitis (PAPS) (2 arms), sponsored by Alexandria University. Primary endpoints: Western Ontario McMasters Universities osteoarthritis index at 4 weeks, Visual Analogue Scale for Anserine bursitis pain severity at 4 weeks and 2 more. Started May 2018; status: completed.
02
Drugs
dextrose
03
Conditions
Pes anserine bursitis (PAPS)
Beyond the preview
Go deeper on NCT04509440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04509440.